ArticleDrugs in R&D2022
Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9.
Theodore J Kottom et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleDrugs in R&D2022
Theodore J Kottom et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.